Nuclear RXRα and RXRβ receptors exert distinct and opposite effects on RA-mediated neuroblastoma differentiation

Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):317-328. doi: 10.1016/j.bbamcr.2018.11.014. Epub 2018 Dec 7.

Abstract

Retinoic acid (RA) promotes differentiation in multiple neurogenic cell types by promoting gene reprogramming through retinoid receptors and also by inducing cytosolic signaling events. The nuclear RXR receptors are one of the main mediators of RA cellular effects, classically by joining the direct receptors of RA, the nuclear RAR receptors, in RAR/RXR dimers which act as transcription factors. Distinct RXR genes lead to RXRα, RXRβ and RXRγ subtypes, but their specific roles in neuronal differentiation remain unclear. We firstly investigated both RXRs and RARs expression profiles during RA-mediated neuronal differentiation of human neuroblastoma cell line SH-SY5Y, and found varying levels of retinoid receptors transcript and protein contents along the process. In order to understand the roles of the expression of distinct RXR subtypes to RA signal transduction, we performed siRNA-mediated silencing of RXRα and RXRβ during the first stages of SH-SY5Y differentiation. Our results showed that RXRα is required for RA-induced neuronal differentiation of SH-SY5Y cells, since its silencing compromised cell cycle arrest and prevented the upregulation of neuronal markers and the adoption of neuronal morphology. Besides, silencing of RXRα affected the phosphorylation of ERK1/2. By contrast, silencing of RXRβ improved neurite extension and led to increased expression of tau and synaptophysin, suggesting that RXRβ may negatively regulate neuronal parameters related to neurite outgrowth and function. Our results indicate distinct functions for RXR subtypes during RA-dependent neuronal differentiation and reveal new perspectives for studying such receptors as clinical targets in therapies aiming at restoring neuronal function.

Keywords: Neuronal differentiation; RXR receptors; Retinoic acid; SH-SY5Y.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle Checkpoints / physiology
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Cell Proliferation / drug effects
  • Dopaminergic Neurons / physiology
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • MAP Kinase Signaling System / physiology
  • Neurites / metabolism*
  • Neuroblastoma / genetics
  • Neuroblastoma / metabolism
  • Rats
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Retinoic Acid / metabolism
  • Receptors, Retinoic Acid / physiology
  • Retinoid X Receptor alpha / metabolism
  • Retinoid X Receptor alpha / physiology*
  • Retinoid X Receptor beta / metabolism
  • Retinoid X Receptor beta / physiology*
  • Retinoid X Receptors
  • Signal Transduction / drug effects
  • Transcriptional Activation
  • Tretinoin / metabolism
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured

Substances

  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Retinoic Acid
  • Retinoid X Receptor alpha
  • Retinoid X Receptor beta
  • Retinoid X Receptors
  • Tretinoin